• Various biopharmaceuticals, such as ADCs and CAR-T therapies that have recently gained attention, share a common key element: antibodies.

• Y-Biologics has established a world-leading fully human antibody library based on our proprietary antibody discovery platform. With numerous out-licensing experience, we have developed various forms of novel biologics through open innovation.